BHC

Bausch Health Companies Stock Price

26.95
-0.57 (-2.07%)
Upgrade to Real-Time
Afterhours (Closed)
26.95
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Bausch Health Companies Inc BHC NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.57 -2.07% 26.95 18:24:07
Open Price Low Price High Price Close Price Prev Close
27.36 26.63 27.51 27.01 27.52
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
24,221 3,941,769 $ 27.02 $ 106,487,303 3,361,485 11.15 - 30.50
Last Trade Time Type Quantity Stock Price Currency
19:36:40 10 $ 27.00 USD

Bausch Health Companies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.57B 355.15M 311.92M $ 8.79B $ -615.40M - -4.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Bausch Health Companies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BHC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.5027.8124.0426.307,270,4442.4510.0%
1 Month20.0727.8119.5223.773,840,0086.8834.28%
3 Months17.2627.8116.0820.403,693,0339.6956.14%
6 Months18.1127.8114.8618.474,043,4748.8448.81%
1 Year30.1230.5011.1518.714,660,688-3.17-10.52%
3 Years23.7031.9911.1521.734,251,4833.2513.71%
5 Years23.7031.9911.1521.734,251,4833.2513.71%

Bausch Health Companies Description

Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in four segments: Bausch+Lomb and international (55% of revenue), Salix pharmaceuticals (25%), ortho dermatology (6%), and diversified products (14%), and approximately 13% of revenue is attributable to non-U.S. markets. Bausch is the market leader in consumer visioncare in India and China, and the fourth-largest visioncare company by sales in the United States.


Your Recent History
NYSE
BHC
Bausch Hea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.